chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chesty cough; Stuff nose; Wheezing; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old, non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route on 18Apr2021 at 13:15 in the left arm (at the age of 42-years-old) as single dose for COVID-19 immunisation. The medical history of the patient included eosinophilic pneumonia. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included inhalers from an unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccination within 4 weeks of COVID vaccine. Previously, the patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route on 28Mar2021 at 12:15 (at the age of 42-years-old) in the left arm as single dose for COVID-19 immunisation. On 21Apr2021, at 12:00 hours, the patient experienced chesty cough and stuff nose at night wheezing. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events of chesty cough, stuff nose and wheezing were recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
(5/28) - Fatigue, chills, fever (100.3), aches, general malaise lasting approximately 24 hours. (5/29) - lingering aches but everything else had passed (5/30) - back to normal
After 2nd Pfizer shot (1-25-2021) FINE FOR 6 HRS. THEN SLEPT 36 HRS!Had Covid antibody test in MA in early June and had NO antibodies!! Please advise-- should I have the shots again or a booster. My Dr. here in MA says she doesn't know as CDC hasn't issued any guidance. I am immunocompromised with RA but stayed off the Plaquenil after the first shot (Jan 4, 2021) till 2 weeks after the 2nd shot to Rev up my immune system.
About 4 hours after injection had chills, and headache similar to caffeine withdrawal.   About 7 hours later more intense chills, body felt hot [ no increased temperature] and slight nausea.  This lasted until early morning hours
My dad died in his sleep 3days after his booster shot- he had no known Heath problems- his only issues with aging were mobility
Nausea, headache, chills and fever. Tiredness and muscle aches for 4 days
Sever abdominal pain, abdominal cramps, diarrhea, cold sweat, severe headaches, extreme fatigue
This spontaneous report has been received from a registered nurse concerning a 4 year old male patient. The patient had no medical history, drug allergies or concurrent conditions. The patient's concomitant therapies included loratadine (CLARITIN) (also reported as Claritin). On 12-SEP-2017, the patient was vaccinated with a dose of PROQUAD with lot number N009773 and expiration date on 28-SEP-2018 (also reported as 20-SEP-2018) (dose, dose number, route of administration and anatomical location were not provided), administered for prophylaxis instead of a dose of VARIVAX. It was reported that the patient did not sought medical attention, no treatment was given for the event and no lab diagnostics or studies were performed. No adverse effects were reported, therefore the patient's present status at the time of reporting was reported as recovered.
After receiving the GARDASIL vaccine patient lost her periods. They came back but very infrequently. When they do come she experienced severe pain and headaches.
Pain, redness, swelling at injection site, lethargy, Rash on (R) elbow began 12/15/07, now resolved (resolved 6 hr 12/19/07) 12/23/07 shortness of breath after walking outdoors, rash on bilateral palms. Unresolved as of 12/26/07. No hives, itching, or tachycardia per patient.
Immediately following last vaccine which was MCV4, client began sweating and became pale.  Stated "He did not feel good."  Orange juice was given, BP was 60/38, 80/60, then he was moved to the floor.  BP increased to 110/60, 110/80.  Remained supine for 10 minutes.  Stated he felt better.
Urticaria and symptomatic dermatographism, intermittent, responds to Zyrtec, still happening now but seems to be improving
FLARE UP OF HIDRADENITIS SUPPURATIVA; This spontaneous report received from a patient concerned a 36 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included hidradenitis suppurativa. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 28-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced flare up of hidradenitis suppurativa. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from flare up of hidradenitis suppurativa. This report was non-serious.; Sender's Comments: V0: Medical Assessment comment not required per standard procedure as the case is assessed as non-serious.
Superficial Phlebitis R calf in patient on Eliquis for coagulopathy 2 weeks after 2nd shot.
Within a few hours of the vaccine, my menstruation began.  At first, it was a light spotting, then was a light-medium flow.  The symptoms also mimicked a cycle:  tightness in pelvis and very light cramping.  I am SUPER regular, so there is no doubt in my mind that this is related to the vaccine.  I keep track of ?my first period day? on paper each month.  Never have I had a intra-cycle period of light-medium flow.  Maybe a light spot upon ovulation.  But, just as quickly at it came, it left.  By the end of the day/next morning, it was gone.  It was like something passing through me:  in one moment, out the next.
joint pain all over her body / beginning in the feet and working its way upwards towards the rest of the body; began to experience flu like symptoms; fatigue; body aches; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 77-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date).   On 30th September 2019, the patient received the 2nd dose of Shingrix. On 30th September 2019, 8 hrs after receiving Shingrix, the patient experienced influenza-like symptoms, fatigue and general body pain. On 2nd October 2019, the patient experienced joint pain. On an unknown date, the outcome of the influenza-like symptoms, fatigue and general body pain were resolved with sequelae and the outcome of the joint pain was recovering/resolving.   It was unknown if the reporter considered the influenza-like symptoms, fatigue, general body pain and joint pain to be related to Shingrix.  Additional case details were reported as follows: The case was reported by patient's wife. The patient experienced  flu like symptoms described as body aches and fatigue that resolved after a few days. The patient also experienced  joint pain all over her body, which was described as intermittent, beginning in the feet and working its way upwards towards the rest of the body. The reporter consented to follow up.
Sore arm; Initial information was received on 07-Oct-2021 regarding an unsolicited valid non-serious case received from a consumer/non-health care professional (patient) via social media.  This case involves adult and unknown gender patient who experienced sore arm (pain in extremity) while receiving INFLUENZA VACCINE and COVID-19 VACCINE.  Past medical treatment(s), vaccination(s) concomitant medication and family history were not provided.  It was unknown if the patient had any medical history, concomitant disease or risk factor.  On an unknown date in last week, the patient received booster dose of suspect COVID-19 VACCINE not produced (batch number and expiry date were not reported) via unknown route in unknown administration site for prophylactic vaccination.  On 06-Oct-2021 (yesterday), the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiry date were not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious sore arm (pain in extremity) (unknown latency) following the administration of INFLUENZA VACCINE and COVID-19 VACCINE.  It was unknown if the patient experienced any additional symptoms/events.  There were no lab data/results available.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was unknown for the event.  There will be no information available on the batch number for this case.
Moderna in the fridge was stored for 31,32, and 33 days; The Moderna in the fridge was stored for 31, 32, and 33 days; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The Moderna in the fridge was stored for 31, 32, and 33 days) and PRODUCT STORAGE ERROR (Moderna in the fridge was stored for 31,32, and 33 days) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007J21-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (The Moderna in the fridge was stored for 31, 32, and 33 days). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna in the fridge was stored for 31,32, and 33 days). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The Moderna in the fridge was stored for 31, 32, and 33 days) and PRODUCT STORAGE ERROR (Moderna in the fridge was stored for 31,32, and 33 days) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The vial was initially stored in the refrigerator on 15-Jan-2022. The vial did not undergo any temperature excursions.  No treatment medications were reported.   This case was linked to MOD-2022-493666, MOD-2022-493669 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Feb-2022: Follow up received include no new information.
Localized Sweeling, Redness,hard to touch left thigh at Vaccine site. Mar 02 Treatment In ER Motrin, Benadryl and HCTC Cream
Fever up to 101 in 24 hours. Respiratory symptoms, grunting, pharyngeal pain, hoarseness of voice. 05/16/2000. Re: need for consent. will send. 05/17/2000 Consent sentto parent. 06/21/2000 2nd request sent. 07/28/2000 Unable to reach by phone-recording it's disconnected. 3rd and final request for consent mailed. Did not follow thru with mailing. MD's office says they moved but don't have the address. # was given for dad's work also listed as disconnected. Case closed for lack of means to obtain additional data. 05/16/2000. pt was hospitalized for only four for observation. Finally recovered. Now beleive the vaccines are responsible for child's sx's according to MD. MD will send for med record or request of consent. 07/28/2000 Call to reporter to request an updated address or phone for parents.
On 10/18/04 pt received Influenza vaccine. He became irritable and febrile. On 10/20/04, he had a generalized seizure with fever (105F)
Tinnitus; This is a spontaneous report received from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: EN6203) via an unspecified route of administration in the left arm on 04Mar2021 at 14:30 as single dose (at the age of 62-year-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: EN6955) via an unspecified route of administration in the left arm, on 25Mar2021 at 09:30 as single dose (at the age of 62-year-old) for COVID-19 immunisation. The patient medical included rheumatoid arthritis. Concomitant medication includes methotrexate (MANUFACTURER UNKNOWN), hydroxychloroquine (MANUFACTURER UNKNOWN), LEUCOVORIN [FOLINIC ACID] (MANUFACTURER UNKNOWN), low-dose naltrexone (LDN) (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient had no known allergies. Prior to vaccination, the patient has not been diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 08Mar2021, the patient experienced tinnitus, ringing in ears which was never before, and was constant. The patient did not received any treatment for the reported adverse event. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event tinnitus was not resolved.   No follow-up attempts are needed. No further information expected.  Amendment: This follow-up report is being submitted to amend previously reported information: Vaccination Facility information, Best Doctor details added, Concomitant drug leucovorin code as LEUCOVORIN [FOLINIC ACID]. In narrative solution for injection as unspecified route of administration, the patient had no known allergies. Prior to vaccination, the patient has not been diagnosed with COVID-19 was added.
Shot on 3/18/21 - in the next hour started feeling dizzy. Had mild flu like symptoms the next day (chills, felt warm, tired, headache, body aches). Flu like symptoms went away. Dizziness and headaches stuck around after other symptoms went away - continued to get worse. Dizziness was enough that it felt unsafe to walk down stairs. A constant feeling of being unsteady and feeling like stood up to fast. Headaches continues to worsen - feeling like an ice cream headache - that really intense sharp pain in front forehead.  Started have episodes of internal crushing feeling/like a low blood pressure feeling. Tried over the counter Tylenol didn't help much for headaches. 3/29/21 - went to Dr - his inital thoughts was probably vaccine related and hoped would continue to improve. He checked vitals. Headaches and dizziness continued. Had hard time tracking - like watching tv - felt like motion sickness.  Making hard to do daily tasks. 4/11/21 - went to see eye Dr. as eye pressure/pain was intense along with the headaches for several days before going in. He checked eye pressure, looked for clots etc. Saw no issues.  Over the next couple of weeks - eye pain improved to more manageable but alway slighty there in right eye. Heaches no longer the ice cream like heaches, but still always there, up front in forehead area and can never get rid of it. Over the counter tylenol doesn't really seem to help. Dizziness improved to be able to feel more confident doing things like stairs. 5/11/21 - Went to see Dr. as headaches are always there and making it hard to go to sleep and will wake up in middle of night with headache. He did labs to see if there was medical issue for headaches - could find nothing.
Blood clot in right eye, headache frontal lobe and over right eye. Dizziness upon standing. Can not look directly into light. Left arm very sore
Patient had the Jynneos vaccine too early, 18 days after the first dose, the second dose was administered.; Second dose of Jynneos administered at dose of 0.1 milliliter intradermally.; Case reference number US-BN-2022-003278 is a spontaneous case report initially received on 23-Sep-2022 from other health professional via Company (reference number: USBAV22-1517) and concerns an adult male patient.  The patient's medical history and concomitant medication details were not reported.  On 12-Aug-2022, the patient was vaccinated with the first dose of Jynneos (smallpox and monkeypox vaccine, live, nonreplicating; batch number: FDP00012), at a dose reported as 0.5ml, subcutaneously, for monkeypox prophylaxis.  On 30-Aug-2022, 18 days after the first dose, the patient was vaccinated with the second dose of Jynneos (batch number: FDP00012), at a dose reported as 0.1 ml, intradermally (explicitly coded as 'inappropriate schedule of vaccine administered' and 'intradermal injection').  At the time of this report, it was unknown if the patient experienced any adverse event due to Jynneos.  Additional information received from Bavarian Nordic on 23-Sep-2022 included the local BN case ID.  This case is linked with US-BN-2022-003274 and US-BN-2022-003280 due to the same reporter.; Reporter's Comments: An adult male patient was vaccinated with the second dose of Jynneos, at a dose reported as 0.1 ml, intradermally, on the day 18 after the first dose, which is considered as inappropriate schedule of vaccine administered and intradermal injection. At the time of this report, it was unknown if the patient experienced any adverse event due to Jynneos. Inappropriate schedule of product administration and intradermal injection are considered as listed per company convention. The patient's medical history and concomitant medication details were not reported. Inappropriate schedule of product administration and intradermal injection have been considered as not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: An adult male patient was vaccinated with the second dose of Jynneos, at a dose reported as 0.1 ml, intradermally, on the day 18 after the first dose, which is considered as inappropriate schedule of vaccine administered and intradermal injection. At the time of this report, it was unknown if the patient experienced any adverse event due to Jynneos. Inappropriate schedule of product administration and intradermal injection are considered as listed per company convention. The patient's medical history and concomitant medication details were not reported. Inappropriate schedule of product administration and intradermal injection have been considered as not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
15 min after administration  there was localized, redness, swelling and itching at the administration site.
Immediate small welph at site (R) T increased in size measurements:2-2 1/2 BENADRYL given 1/4 tsp.
Mandatory EUA Reporting - Patient received COVID-19 vaccine on 1/12/21 and then tested positive for Covid the same day. Was admitted to hospital from rehab (resides in rehab for chronic respiratory failure). Patient deteriorated throughout hospitalization, was transitioned to comfort care, and expired on 2/10/21.
Swelling; irritation under armpits (lymphnodes); mild pain; mild itching that developed into a welt; Itching/itching sensation; light sorness for 2-3 days at the injection site; Light headedness; heat wave sensation; Rapid heart rate; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (Light headedness), TEMPERATURE INTOLERANCE (heat wave sensation), HEART RATE INCREASED (Rapid heart rate), PAIN (mild pain) and VACCINATION SITE URTICARIA (mild itching that developed into a welt) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Dec-2020, the patient experienced DIZZINESS (Light headedness), TEMPERATURE INTOLERANCE (heat wave sensation), HEART RATE INCREASED (Rapid heart rate) and VACCINATION SITE PAIN (light sorness for 2-3 days at the injection site). On 08-Jan-2021, the patient experienced PAIN (mild pain), VACCINATION SITE URTICARIA (mild itching that developed into a welt), VACCINATION SITE PRURITUS (Itching/itching sensation) and AXILLARY PAIN (irritation under armpits (lymphnodes)). On 11-Jan-2021, the patient experienced VACCINATION SITE SWELLING (Swelling). At the time of the report, DIZZINESS (Light headedness), TEMPERATURE INTOLERANCE (heat wave sensation), HEART RATE INCREASED (Rapid heart rate) and VACCINATION SITE PAIN (light sorness for 2-3 days at the injection site) had resolved and PAIN (mild pain), VACCINATION SITE URTICARIA (mild itching that developed into a welt), VACCINATION SITE PRURITUS (Itching/itching sensation), VACCINATION SITE SWELLING (Swelling) and AXILLARY PAIN (irritation under armpits (lymphnodes)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.   No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Patient details updated; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded
itching; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced itching on an unspecified date. Outcome of event was resolved on an unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021366674 Same reporter/drug/event for different patients.
Patient reported having severe headache on evening of 4/21 and most of the day on 4/22.  This morning she discovered dried blood in both ears and wet blood upon cleaning. She has had no pain in either ear
Got VERY sick; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown.   It was unknown if the reporter considered the sickness to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient received Shingrix and got very sick. The patient was scared to get second shot.
Woke up with sharp chest pain, radiating down left side/arm. Assoc with SOB, diaphoresis. Seen at ER had pos troponin, EKG changes. Admitted had neg heart cath.
Vaccine administered on 6/9/15. Rash developed on 6/10. By 6/12 red, itchy rash spread down entire right arm. Patient went to walk-in clinic. Diagnosed with cellulitis. Treated with KEFLEX, rash resolved completely.
patient received covid 19 booster on 9/19/22.  it was noticed that the vaccine was given from an exoired vial . the vial was opened on 9/16/22.   patients caretaker has been notified that the booster is considered invalid
Vomited twice over a 2-hour time period, then seemed fine. No fever or other symptoms. No medications or treatments were given.